Filing Details
- Accession Number:
- 0001628280-24-050107
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-05 17:03:28
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-12-05 17:03:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-01 | 76 | $1.15 | 5,700,097 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-04 | 49 | $1.17 | 5,700,146 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-05 | 76 | $1.20 | 5,700,222 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-06 | 76 | $1.20 | 5,700,298 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-07 | 76 | $1.17 | 5,700,374 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-08 | 76 | $1.18 | 5,700,450 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-11 | 76 | $1.20 | 5,700,526 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-12 | 76 | $1.20 | 5,700,602 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-13 | 76 | $1.20 | 5,700,678 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 76 | $1.19 | 5,700,754 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-15 | 76 | $1.17 | 5,700,830 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-18 | 76 | $1.18 | 5,700,906 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-19 | 76 | $1.15 | 5,700,982 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-20 | 85 | $1.13 | 5,701,067 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-21 | 85 | $1.09 | 5,701,152 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-22 | 75 | $1.07 | 5,701,227 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-25 | 75 | $1.09 | 5,701,302 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-26 | 75 | $1.11 | 5,701,377 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-27 | 75 | $1.15 | 5,701,452 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-11-29 | 75 | $1.32 | 5,701,527 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Billionaire Hedge Funds
